BioSoteria

Subpage Introduction Image

... I hope to work with BioSoteria in every startup that I do.

M. J. Whitehouse, JumpStart BioDevelopment

View More Testimionials

Events

  • September 24, 2010

    Get Ready for the 2010 Pacific Drug Safety Summit!

    The 2010 Pacific Drug Safety Summit is scheduled for September 24, 2010. If you are interested in attending or sponsoring this year’s event, email .(JavaScript must be enabled to view this email address) today.

    CLICK HERE TO VIEW PDSS09 INFORMATION.

    Click Here to download more information on the most recent Bay Area Drug Safety Event. Check back often for details on PDSS10 as they become available!

  • June 13, 2010 – June 17, 2010

    The 46th Annual Meeting of the Drug Information Association

    BioSoteria will be presenting and exhibiting at the DIA’s 46th Annual Meeting - the industry’s ultimate venue for blending multidisciplinary learning with global networking opportunities.
    Monday, June 14, 3:30-5:00 pm, Balancing Computational Power with Clinical Prowess in Safety Signal Detection, Dr. Sally Van Doren, Session Chair
    Thursday, June 17, 8:30-10:00 am, Expanding Pharmacovigilance Training Beyond SOPs without Blowing Your Budget, Michelle N. Flewell, CPLP, Presenter
    Visit BioSoteria in Booth 2217!

  • April 23, 2010

    Risk-Benefit Considerations in Drug Regulatory Decision-Making

    BioSoteria is sponsoring this conference, which is presented by FDA and The New York Academy of Sciences (NYAS). The forum will address the following key issues:

    Creation of a formalized, systematic approach for assessing drug risks and benefits
    Approaches for immediately improving the examination of drug risks and benefits
    Ways to improve the transparency and communication of FDA decisions to the general public

    Visit the NYAS website for details and registration information.

  • March 2, 2010

    Implementing and Executing Risk Management Systematically

    This complimentary Web Symposium will provide an insightful view into the processes and resources required to effectively implement and execute risk management initiatives within an organization.

    Speakers:
    Sally Van Doren, PharmD, President, CEO and Founder, BioSoteria, Inc.
    Allison Bond, PhD, Head of Pharmacovigilance, Quanticate, Inc.
    Karen E. Jaffe, Director of Product Strategy, Oracle

    View the Program and Register

  • January 11, 2010 – January 13, 2010

    DIA Pharmacovigilance and Risk Management Workshop

    Dr. Sally Van Doren of BioSoteria will be presenting the Integrated Summary of Safety.
    Representatives from BioSoteria will be available at the company’s tabletop exhibit to discuss drug safety solutions.

Drug Safety Intelligence

Subscribe to DSI, BioSoteria´s complimentary weekly summary of drug safety news.

Newsletter Sign Up

eLadder Safety in Action

View the key features of eLadder™ Safety, the first and only comprehensive eLearning curriculum in pharmacovigilance.

eLadder Safety DEMO